BRIEF-Alumis And Acelyrin To Merge Creating A Late-Stage Clinical Biopharma Company-February 2024-www.financetom.com

BRIEF-Alumis And Acelyrin To Merge Creating A Late-Stage Clinical Biopharma Company

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Alumis And Acelyrin To Merge Creating A Late-Stage Clinical Biopharma Company

Feb 6, 2025 3:32 PM

Feb 6 (Reuters) - Alumis Inc ( ALMS ):

* ALUMIS AND ACELYRIN TO MERGE CREATING A LATE-STAGE

CLINICAL

BIOPHARMA COMPANY DEDICATED TO INNOVATING, DEVELOPING AND

COMMERCIALIZING TRANSFORMATIVE THERAPIES FOR IMMUNE-MEDIATED

DISEASES

* ALUMIS INC ( ALMS ): ALUMIS ( ALMS ) & ACELYRIN STOCKHOLDERS TO OWN ABOUT

55% &

ABOUT 45%, RESPECTIVELY, OF COMBINED CO ON FULLY DILUTED BASIS

* ALUMIS INC ( ALMS ): COMBINED COMPANY WILL OPERATE UNDER ALUMIS

NAME WITH

CURRENT ALUMIS EXECUTIVE TEAM

* ALUMIS INC ( ALMS ): UNDER DEAL, ACELYRIN STOCKHOLDERS TO RECEIVE

0.4274

SHARES OF ALUMIS COMMON STOCK FOR EACH SHARE OF ACELYRIN COMMON

STOCK OWNED

* ALUMIS INC ( ALMS ): ALUMIS ( ALMS ) & ACELYRIN'S ( SLRN ) COMBINED PRO FORMA CASH

POSITION

OF ABOUT $737 MILLION AS OF DEC 31, 2024, PROVIDES RUNWAY INTO

2027

Source text:

Further company coverage:

Previous page： Corporacion Inmobiliaria Vesta Q3 FFO, Revenue Increase Next page： Carlyle Credit Income Fund Prices Offering of Preferred Shares

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Corporacion Inmobiliaria Vesta Q3 FFO, Revenue Increase

Oct 23, 2025

05:42 PM EDT, 10/23/2025 (MT Newswires) -- Corporacion Inmobiliaria Vesta (VTMX) reported Q3 funds from operations late Thursday of $0.0552 per share, up from $0.0460 a year earlier. Revenue for the quarter ended Sep. 30 was $72.4 million, up from $63.7 million a year earlier. ...

Carlyle Credit Income Fund Prices Offering of Preferred Shares

Oct 23, 2025

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ( CCIF ) (the “Fund”) today announced that it has priced an underwritten public offering of 1.2 million shares of its 7.375% Series D Preferred Shares due 2028 (the “Preferred Shares”) at a public offering price of $25 per share, which will result in net proceeds to the...

Applied Materials Plans Workforce Reduction in Drive to Enhance Productivity

Oct 23, 2025

05:44 PM EDT, 10/23/2025 (MT Newswires) -- Applied Materials ( AMAT ) said late Thursday that it has approved a plan to cut about 4% of its global workforce to boost efficiency and competitiveness. The company expects $160 million to $180 million in charges, mainly for severance, mostly recognized in fiscal Q4, 2025. The plan is slated for completion in...

Byline Bancorp Q3 Adjusted Earnings, Revenue Rise

Oct 23, 2025

05:48 PM EDT, 10/23/2025 (MT Newswires) -- Byline Bancorp ( BY ) reported Q3 non-GAAP net income late Thursday of $0.83 per diluted share, up from $0.70 a year earlier. Analysts polled by FactSet expected $0.72. Revenue in the three months ended Sept. 30 rose to $115.7 million from $101.8 million a year earlier. Analysts expected $111.1 million. The company...